KGK Science Inc.
Andrew Charrette has over a decade of experience in regulatory affairs, project management, and medical writing, with a focus on the natural health product industry and clinical trials. Currently serving as the Director of Regulatory Affairs and Psychedelic Advisor at KGK Science Inc. since July 2013, Andrew has held several key positions including Senior Manager of Regulatory Affairs and Operations Director, ensuring the efficient management of clinical trial applications and quality assurance processes. Prior experience includes a role as a Medical Writer at Mediprobe Research Inc. and an Information Analyst at Brogan Inc. Andrew holds a Master of Science in Neuroscience from the University of Ottawa and a Bachelor of Medical Science in Pharmacology and Physiology from Western University.
This person is not in any teams
KGK Science Inc.
Since 1997, KGK Science has played a key role in the natural health product industry by providing our clients with high-quality clinical research and regulatory expertise to bring safe and effective products to global markets. As a full-service premium contract research organization (CRO) supporting the nutraceutical, cannabis and hemp industries, KGK is one of the most reliable resources for brands looking for an experienced, trustworthy team of scientific researchers, consultants, and regulatory specialists to develop customized claim substantiation and path-to-market strategies. From clinical study design to impactful product marketing, KGK has client success down to a science. At our state-of-the-art clinical research facilities, clinical staff, researchers, and regulatory experts quickly turn requests into results. We’ve guided hundreds of companies in taking their initial product concepts on to clinically proven claims and beyond, working to differentiate ideas and offer unique pathways through complex regulatory bodies including Health Canada, FDA, and FTC. Recognized globally as thought-leaders in cannabinoid science and regulation for the natural health product industry, KGK Science is proudly the first CRO in Canada to possess a Cannabis Research License, extending our 22 years of industry experience to include cannabis and hemp-derived products. As the leading CRO in the cannabis industry, KGK is focused on expertly conducting clinical trials and providing regulatory support to help bring innovative new health products to market, continuing to further global research and unlock the true value of the cannabis industry for clients and consumers.